Alex Zhavoronkov, PhD, Contributor

Author's posts

Women In Longevity Medicine: Dr. Dina Radenkovic

The longevity medicine industry is rapidly evolving and we are witnessing the advent of a new profession – longevity physician. Incorporating deep aging clocks in her diagnostic and therapeutic practice, Dr. Dina Radenkovic, a war survivor turned longe…

Deep Dive Into Big Pharma AI Productivity: One Study Shaking The Pharmaceutical Industry

The pharmaceutical business is perhaps the only industry on the planet, where to get the product from idea to market the company needs to spend about a decade, several billion dollars, and there is about 90% chance of from the time it takes from discov…

This Stanford Scientist Can Make You Feel And Think Younger: Interview With Dr. Laura Carstensen

Aging is a multifactorial process affecting every aspect of our lives. As we age our psychology and behavior changes. In this article, I interviewed the world’s most influential expert on the psychology of aging, Dr. Laura Carstensen

Biotechnology In the Time of COVID-19: Past, Present, and Future

Despite popular belief, the biotechnology and biopharmaceutical industry suffered immense losses as a result of the COVID-19 pandemic. As many hospitals have surpassed maximum capacity, clinical trials that cost billions of dollars had to be paused or …

The Rise of the Deep: Eric Topol’s Deep Medicine To Stand The Test Of Time

Deep Medicine not only provides a helicopter view of AI for drug discovery and development but goes further into the limitations, regulatory and ethical considerations. It talks about many aspects that go beyond the capabilities of state-of-art AI, suc…

How To Live This Life Better: Effective Altruism In The Context Of Longevity

A quantified approach to altruism in the form of counting the quality-adjusted life years (QALY) generated globally may help humans and AI make better life decisions. One of the most effective ways to maximize global QALY is to contribute to the emergi…

Longevity Vision Fund: Fueling The Longevity Biotechnology Boom We’ve Been Waiting For

The longevity industry gets a boost with the launch of a $100 million venture fund, Longevity Vision Fund, focused on longevity biotechnology and artificial intelligence. The fund will invest in infrastructure projects enabling the longevity biotechnol…